pamidronate has been researched along with Carcinoma, Papillary in 1 studies
Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
Excerpt | Relevance | Reference |
---|---|---|
"We found that urinary markers of bone resorption are best measured on 2-hour fasting samples, because results on random urine showed poor precision and less decline with therapy." | 2.69 | Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates. ( Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosen, HN | 1 |
Moses, AC | 1 |
Garber, J | 1 |
Ross, DS | 1 |
Lee, SL | 1 |
Greenspan, SL | 1 |
1 trial available for pamidronate and Carcinoma, Papillary
Article | Year |
---|---|
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorptio | 1998 |